Exagen Inc. Made Big Gain
Exagen Inc. (XGN:NASDAQ) rocketted at $12.77, representing a gain of 24.6%. On Mon, Aug 09, 2021, XGN:NASDAQ touched a New 2-Week Low of $10.25. The stock got featured on our News Catalysts scanner on Mon, Aug 09, 2021 at 05:21 PM in the 'EARNINGS' category. From Mon, Jul 26, 2021, the stock recorded 20.00% Up Days and 9.09% Green Days
The share price of the company has been moving sideways in recent weeks.
About Exagen Inc. (XGN:NASDAQ)
Exagen Diagnostics Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets four products under its Avise brand to provide an accurate, timely and differential diagnosis and to optimize the treatment of ARDs. It processed approximately 9,300 patient specimens for its diagnostic product line, Avise SLE. It markets and sells solutions to community rheumatologists.
Top 10 Gainers:
- Fulcrum Therapeutics, Inc. (FULC:NASDAQ), 125.33%
- ZEV (ZEV:NYSE), 80.97%
- SC Health Corporation (SCPE:NYSE), 53.11%
- Mediaco Holding Inc. (MDIA:NASDAQ), 36.3%
- Exagen Inc. (XGN:NASDAQ), 24.59%
- ORPH (ORPH:NASDAQ), 24.58%
- ACHL (ACHL:NASDAQ), 22.13%
- FSR (FSR:NYSE), 21.56%
- Cortexyme, Inc. (CRTX:NASDAQ), 21.53%
- 3D Systems Corporation (DDD:NYSE), 21.48%